We also confirmed that PLA2G2A, identified as an upregulated gene in the tumor and directly regulated by AR in network #3, to be inhibited by DHT treatments in the cultured LNCaP cells (Figure 4). The gene discussed is PLA2G2A; the disease is neoplasm.